Tryp Therapeutics Inc.

TRYPF · OTC
Analyze with AI
2/29/2024
11/30/2023
8/31/2023
5/31/2023
Operating Activities
Net Income-$3-$1,161-$1,690-$656
Dep. & Amort.$0$0-$128$128
Deferred Tax$0$0$128-$128
Stock-Based Comp.$0$28$18$54
Change in WC$0-$17$167-$51
Other Non-Cash-$4$180$386-$90
Operating Cash Flow-$7-$969-$1,119-$743
Investing Activities
PP&E Inv.$0$0$0-$8
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0-$0
Investing Cash Flow$0$0$0-$8
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$5,401$2,667$183$1,963
Financing Cash Flow$5$2,667$183$1,963
Forex Effect$0$0$0$0
Net Chg. in Cash-$1$1,698-$936$1,212
Supplemental Information
Beg. Cash$2$398$1,334$122
End Cash$1$2,096$398$1,334
Free Cash Flow-$7-$969-$1,119-$751
Tryp Therapeutics Inc. (TRYPF) Financial Statements & Key Stats | AlphaPilot